Form FDA 483s

Form FDA 483 Issued to Paula R. Bickle Ph.D., Cascade Consultants Research Foundation. 1999-09-08 [DMPS IND trials sponsored by Heyltex Inc.]: http://www.circare.org/foia2/483_bickle.pdf

Form FDA 483 Issued to Richard L. Borison M.D. 1997-04-22: http://www.bioethicswatch.org/foia/borison483_19970422.pdf

Form FDA 483 Issued to Richard L. Borison M.D. 1993-06-24: http://www.bioethicswatch.org/foia/borison483_19930624.pdf

Form FDA 483 Issued to L. Terry Chappell M.D., Great Lakes College of Clinical Medicine Institutional Review Board. 1999-12-01: http://www.circare.org/foia2/483_glccm19991201.pdf

Form FDA 483 Issued to L. Terry Chappell M.D., Great Lakes Association of Clinical Medicine Institutional Review Board. 1994-12-21: http://www.circare.org/foia2/483_glccm19941221.pdf

Form FDA 483 Issued to Arnold E. Eggers M.D., SUNY Health Sciences Center. 1995-04-19: http://www.bioethicswatch.org/foia/483_eggers.pdf

Form FDA 483 Issued to James A. Holland M.D., Stratton VA Medical Center. 2003-01-02: http://www.bioethicswatch.org/foia/strattonva483_20030102.pdf

Form FDA 483 Issued to Kevin L. Keim Ph.D., Quintiles Pacific, Inc. 1999-01-13 [NDA 20-823 Novartis Exelon]: http://www.bioethicswatch.org/foia/quintiles483_19990113.pdf

El-Hage, A. Correspondence to Kevin L. Keim Ph.D., Quintiles Pacific, Inc. 1999-08-16 [NDA 20-823 Novartis Exelon]: http://www.circare.org/exelon/fda_quintiles_19990816.pdf (1)

Form FDA 483 Issued to Lisa A. Krinsky, SFBC International Inc. 2005-05-02: http://www.bioethicswatch.org/foia/sfbcinternational483_20050502.pdf (2)

Form FDA 483 Issued to Lisa A. Krinsky, SFBC International Inc. 2004-09-15: http://www.bioethicswatch.org/foia/sfbcinternational483_20040915.pdf (2)

Form FDA 483 Issued to Lisa A. Krinsky, SFBC International Inc. 2004-07-23: http://www.bioethicswatch.org/foia/sfbcinternational483_20040723.pdf (2)

Form FDA 483 Issued to Carl R. Lang, M.D., Greater Northwest Medical Group. 2002-12-30 [Ketek™ protocol #3014]: http://www.circare.org/FOIA/lang_fda483_20021230.pdf

Meredith Rigdon Lentz, M.D. Form FDA 483 2001-05-10: http://www.circare.org/fdaeirs/lentz_fda483_20010510.pdf

Meredith Rigdon Lentz, M.D. FDA Establishment Inspection Report 2001-05-10: http://www.circare.org/fdaeirs/lentz_fdaeir_20010510.pdf

For additional information see the FDA warning letter to Dr. Lentz: http://www.circare.org/FOIA/fdawarninglettersftol.htm#l

Form FDA 483 Issued to Antonio R. Pizarro M.D., SFBC Fort Myers. 2005-06-03: http://www.bioethicswatch.org/foia/sfbcinternational483_20050603.pdf (2)

Form FDA 483 Issued to Alkis Togias M.D., Johns Hopkins Asthma & Allergy Clinic. 2001-06-28 [Death of Ellen Roche]: http://www.circare.org/fdawls3/togias483_20010628.pdf

Johns Hopkins University Response to FDA. 2001-07-16: http://www.circare.org/fdawls3/togias_fdareply_20010721.pdf

Form FDA 483 Issued to Johns Hopkins School of Medicine Institutional Review Board. 2001-09-07 [Death of Ellen Roche]: http://www.circare.org/fdawls3/jhuirb_483.pdf

Form FDA 483 Issued to Johns Hopkins Bayview Medical Center Human Subjects Committee. 2001-09-07 [Death of Ellen Roche]: http://www.circare.org/fdawls3/bayviewmc_483.pdf

More Forms FDA 483: FDA Office of Regulatory Affairs ORA Electronic Reading Room

Notes

1. NDA 20-823 Novartis Exelon, Administrative Documents and Correspondence. Accessed on 2007-06-01 at: http://www.fda.gov/cder/foi/nda/2000/20823_Exelon_admincorres.pdf

2. FDA Forms 483 related to SFBC International, Inc., courtesy of John Dorschner and The Miami Herald.

top

Last Updated: 2010-07-27

If you find the information on this page helpful please support CIRCARE with a tax-deductible contribution today. Because CIRCARE doesn't accept funds from pharmaceutical or medical device manufacturers, we depend on contributions from individuals like you to help us advocate for meaningful protection of human subjects in research. Donating on-line with PayPal is quick and easy. Find out more on our Support page

---